Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody therapeutics. The company has developed a proprietary XmAb? technology platform that it uses to develop antibody product candidates designed to treat autoimmune and allergic diseases, cancer and other conditions. The company has developed two stage product candidates: XmAb5871, which is being developed for autoimmune disease; and XmAb7195, which is being developed for asthma and allergic diseases. The company is also developing a pipeline of bispecific antibody candidates including, among others: XmAb14045, which is for the treatment of acute myeloid leukemia.
  • TickerXNCR
  • ISINUS98401F1057
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for XNCR

ValuEngine Rating and Forecast Report for XNCR

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for XNCR

ValuEngine Rating and Forecast Report for XNCR

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for XNCR

ValuEngine Rating and Forecast Report for XNCR

ValuEngine Rating and Forecast Report for XNCR

ValuEngine Rating and Forecast Report for XNCR

ValuEngine Rating and Forecast Report for XNCR

ValuEngine Rating and Forecast Report for XNCR

ValuEngine Rating and Forecast Report for XNCR

ValuEngine Rating and Forecast Report for XNCR

ValuEngine Rating and Forecast Report for XNCR

ValuEngine Rating and Forecast Report for XNCR

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch